AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33583033 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary interventions
Number of subjects: 0
Study 33583033 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants (PNPLA3, TM6SF2, MBOAT7)
Number of subjects: 0
Study 36210311 — intervention group
Group type: EXPERIMENTAL
Intervention: Latissimus dorsi flap
Number of subjects: 107
Study 36210311 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep inferior epigastric artery perforator flap
Number of subjects: 107
Study 36210311 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracodorsal flap and implant
Number of subjects: 107
Study 36210311 — intervention group
Group type: EXPERIMENTAL
Intervention: Expander
Number of subjects: 107
Study 36210311 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-reconstruction)
Number of subjects: 107
Study 33103585 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing educational intervention
Number of subjects: 82
Study 32213342 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous daratumumab (1800 mg co-formulated with 2000 U/mL recombinant human hyaluronidase PH20)
Number of subjects: 522
Study 32213342 — intervention group
Group type: COMPARATOR
Intervention: Intravenous daratumumab (16 mg/kg)
Number of subjects: 522
Study 32213342 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous daratumumab
Number of subjects: 522
Study 32213342 — intervention group
Group type: COMPARATOR
Intervention: Intravenous daratumumab
Number of subjects: 522
Study 34700203 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined household-level piped water and sanitation intervention
Number of subjects: 1045
Study 34700203 — intervention group
Group type: COMPARATOR
Intervention: Control villages (no intervention)
Number of subjects: 1045
Study 33320279 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical conditioning
Number of subjects: 58
Study 33320279 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational learning
Number of subjects: 58
Study 33320279 — intervention group
Group type: COMPARATOR
Intervention: Sham conditioning
Number of subjects: 58
Study 32070386 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial treatment planning
Number of subjects: 25
Study 32070386 — intervention group
Group type: EXPERIMENTAL
Intervention: Replanning after study group meeting
Number of subjects: 25
Study 32070386 — intervention group
Group type: COMPARATOR
Intervention: Initial planning
Number of subjects: 25
Study 32070386 — intervention group
Group type: EXPERIMENTAL
Intervention: Replanning
Number of subjects: 25
Study 36399909 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy (six cycles of 5‐fluorouracil, leucovorin [FU/FA], oxaliplatin [FOLFOX] and panitumumab [Pmab])
Number of subjects: 248
Study 36399909 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy (FU/FA plus Pmab)
Number of subjects: 248
Study 36399909 — intervention group
Group type: COMPARATOR
Intervention: Maintenance therapy (FU/FA alone)
Number of subjects: 248
Study 35213289 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg, Bisoprolol 5 mg, Hydrochlorothiazide 25 mg, Losartan 50 mg daily (GENRES)
Number of subjects: 400
Study 35213289 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg, Losartan 50 mg daily (LIFE-Fin)
Number of subjects: 400
Study 35213289 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg (GENRES)
Number of subjects: 400
Study 35213289 — intervention group
Group type: EXPERIMENTAL
Intervention: Four different antihypertensive drugs (general)
Number of subjects: 400
Study 33439315 — intervention group
Group type: EXPERIMENTAL
Intervention: T2‐FLAIR radiomics signature
Number of subjects: 52
Study 33439315 — intervention group
Group type: EXPERIMENTAL
Intervention: T1‐CE, T2‐FLAIR, T2WI, DWI radiomics signature
Number of subjects: 52
Study 35452458 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 32
Study 35452458 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.25 mcg/kg/min)
Number of subjects: 32
Study 35452458 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (0.5 mcg/kg/min)
Number of subjects: 32
Study 35452458 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (combined dosage)
Number of subjects: 32
Study 32474993 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified release melatonin
Number of subjects: 41
Study 32474993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 32229597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (n = 4,755)
Number of subjects: 9483
Study 32229597 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (n = 4,728)
Number of subjects: 9483
Study 33582256 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM)
Number of subjects: 66
Study 35830845 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted classroom combined with case presentations (test group)
Number of subjects: 59
Study 35830845 — intervention group
Group type: COMPARATOR
Intervention: Control group (only attending pre-clinical training)
Number of subjects: 59
Study 33559157 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial stressor
Number of subjects: 115
Study 33559157 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 115
Study 35733211 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation support for one of four evidence-based practices
Number of subjects: 33
Study 35733211 — intervention group
Group type: COMPARATOR
Intervention: No implementation support for the other evidence-based practices
Number of subjects: 33
Study 35733211 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation support after 18 months
Number of subjects: 33
Study 36384484 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid on-site test (ROST) arm at PLC
Number of subjects: 1128
Study 36384484 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid on-site test (ROST) arm at ACH
Number of subjects: 1128
Study 36384484 — intervention group
Group type: COMPARATOR
Intervention: Standard arm at PLC
Number of subjects: 1128
Study 36384484 — intervention group
Group type: COMPARATOR
Intervention: Standard arm at ACH
Number of subjects: 1128
Study 32776202 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol 5/5 µg
Number of subjects: 9942
Study 32776202 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 5 µg
Number of subjects: 9942
Study 36165878 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo
Number of subjects: 0
Study 36165878 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (10 mg hidden injection)
Number of subjects: 0
Study 36165878 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (hidden injection)
Number of subjects: 0
Study 36165878 — intervention group
Group type: COMPARATOR
Intervention: Natural history control group
Number of subjects: 0
Study 32946500 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF) scheme for malnutrition services
Number of subjects: 6480
Study 32946500 — intervention group
Group type: COMPARATOR
Intervention: Control group with simple budget allocation
Number of subjects: 6480
Study 36302157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise with core temperature increased to +2°C TC
Number of subjects: 12
Study 36302157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise with core temperature increased to +1°C TC
Number of subjects: 12
Study 36302157 — intervention group
Group type: COMPARATOR
Intervention: Cycling exercise without heat stress (thermoneutrality)
Number of subjects: 12
Study 36302157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise with heat stress at +1°C TC
Number of subjects: 12
Study 36302157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise with heat stress at +2°C TC
Number of subjects: 12
Study 36302157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise with heat stress at +1°C TC and +2°C TC
Number of subjects: 12
Study 34914568 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 263
Study 34914568 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 263
Study 33962579 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA PET/CT prior to definitive radiation therapy (dRT)
Number of subjects: 312
Study 33962579 — intervention group
Group type: COMPARATOR
Intervention: Standard dRT
Number of subjects: 312
Study 33962579 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA PET/CT
Number of subjects: 312
Study 32260313 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar dielectric radiofrequency (MDR) treatment (8 sessions of 20 minutes each)
Number of subjects: 66
Study 32260313 — intervention group
Group type: COMPARATOR
Intervention: Sham MDR therapy (8 sessions of 20 minutes each)
Number of subjects: 66
Study 32260313 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study 36216314 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP clinic intervention
Number of subjects: 436
Study 36216314 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 436
Study 36216314 — intervention group
Group type: COMPARATOR
Intervention: STOP clinic intervention and Routine care (control)
Number of subjects: 436
Study 33389715 — intervention group
Group type: EXPERIMENTAL
Intervention: motor‐cognitive dual task training (mCdtt)
Number of subjects: 50
Study 33389715 — intervention group
Group type: EXPERIMENTAL
Intervention: motor‐motor dual task training (mMdtt)
Number of subjects: 50
Study 35726109 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulant Activity Feedback (AAF)
Number of subjects: 0
Study 35726109 — intervention group
Group type: EXPERIMENTAL
Intervention: eMBCT (web-based mindfulness-based cognitive therapy)
Number of subjects: 0
Study 35726109 — intervention group
Group type: COMPARATOR
Intervention: Psycho-education control group (PE)
Number of subjects: 0
Study 34762770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine (DPV) arm
Number of subjects: 168
Study 34762770 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLB) arm
Number of subjects: 168
Study 32871616 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron (IVI)
Number of subjects: 110
Study 32871616 — intervention group
Group type: COMPARATOR
Intervention: Oral iron (OI)
Number of subjects: 110
Study 32871616 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative resolution of anaemia (pooled analysis)
Number of subjects: 110
Study 35908731 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytisine plus counseling (N = 470)
Number of subjects: 869
Study 35908731 — intervention group
Group type: COMPARATOR
Intervention: Counseling alone (N = 399)
Number of subjects: 869
Study 34504409 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass biochar and inorganic fertilizer
Number of subjects: 0
Study 34504409 — intervention group
Group type: EXPERIMENTAL
Intervention: Chat biochar
Number of subjects: 0
Study 34504409 — intervention group
Group type: COMPARATOR
Intervention: Controlled treatments (no biochar)
Number of subjects: 0
Study 35332654 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (≤1.8 mg/day)
Number of subjects: 1184
Study 35332654 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide (0.5 or 1.0 mg/week)
Number of subjects: 1184
Study 36910414 — intervention group
Group type: EXPERIMENTAL
Intervention: Video information in addition to the standard pre‐anaesthetic review
Number of subjects: 37
Study 36910414 — intervention group
Group type: COMPARATOR
Intervention: Standard pre‐anaesthetic review
Number of subjects: 37
Study 34468696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive SBP lowering (<120 mm Hg)
Number of subjects: 9361
Study 33852252 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene 0.005% and betamethasone dipropionate 0.064% foam (Cal/BD)
Number of subjects: 650
Study 32277617 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab combined with nedaplatin
Number of subjects: 100
Study 32277617 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin alone (Control)
Number of subjects: 100
Study 33556409 — intervention group
Group type: EXPERIMENTAL
Intervention: anodal tDCS (a‐tDCS)
Number of subjects: 12
Study 33556409 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 12
Study 32876119 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio‐C Pulpo (n = 36)
Number of subjects: 70
Study 32876119 — intervention group
Group type: COMPARATOR
Intervention: MTA Angelus (n = 34)
Number of subjects: 70
Study 35312188 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized additive mixed model (GAMM)
Number of subjects: 0
Study 35312188 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear multilevel treatment‐by‐covariate interaction
Number of subjects: 0
Study 33480860 — intervention group
Group type: EXPERIMENTAL
Intervention: FitMindKit (12-module psychotherapy intervention)
Number of subjects: 1986
Study 33480860 — intervention group
Group type: COMPARATOR
Intervention: HealthWatch (12-module program providing general health information)
Number of subjects: 1986
Study 32188005 — intervention group
Group type: EXPERIMENTAL
Intervention: Riceberry rice bread (RRB)
Number of subjects: 16
Study 32188005 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bread (WB)
Number of subjects: 16
Study 32188005 — intervention group
Group type: EXPERIMENTAL
Intervention: Hom Mali bread (HMB)
Number of subjects: 16
Study 32188005 — intervention group
Group type: EXPERIMENTAL
Intervention: All breads
Number of subjects: 16
Study 34353070 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop health management (CLHM) system based on an Internet platform
Number of subjects: 102
Study 34353070 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 102
Study 32106837 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic quadrivalent HPV vaccine
Number of subjects: 312
Study 32106837 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HPV vaccination)
Number of subjects: 312
Study 32714385 — intervention group
Group type: EXPERIMENTAL
Intervention: Real stimulation (iTBS on rpSTS)
Number of subjects: 32
Study 32714385 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study 36053072 — intervention group
Group type: EXPERIMENTAL
Intervention: Pandemic period (March 1, 2020 to February 28, 2021)
Number of subjects: 429
Study 36053072 — intervention group
Group type: COMPARATOR
Intervention: Pre pandemic period (March 1, 2019 to February 29, 2020)
Number of subjects: 429
Study 33024556 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic trans-abdominal pre-peritoneal (TAPP) repair using 2 separate meshes
Number of subjects: 180
Study 33024556 — intervention group
Group type: COMPARATOR
Intervention: Open pre-peritoneal (PP) single mesh repair
Number of subjects: 180
Study 33024556 — intervention group
Group type: COMPARATOR
Intervention: Bilateral Lichtenstein repair
Number of subjects: 180
Study 35560107 — intervention group
Group type: EXPERIMENTAL
Intervention: i-Dashboard
Number of subjects: 169
Study 35560107 — intervention group
Group type: COMPARATOR
Intervention: Established EMR
Number of subjects: 169
Study 32244044 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced-strength-training (PST)
Number of subjects: 42
Study 32244044 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced strength-training (SPST)
Number of subjects: 42
Study 32244044 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric strength-training (IST)
Number of subjects: 42
Study 32244044 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 35790915 — intervention group
Group type: EXPERIMENTAL
Intervention: IMA intervention (shared decision-making intervention based on the Theoretical Model of Non-initiation)
Number of subjects: 24
Study 35790915 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 24
Study 35362891 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost
Number of subjects: 116
Study 35362891 — intervention group
Group type: COMPARATOR
Intervention: PSMA-PET/CTpre
Number of subjects: 116
Study 35362891 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost (≤ 1 week)
Number of subjects: 116
Study 35362891 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost (12 weeks)
Number of subjects: 116
Study 35362891 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost (25 weeks)
Number of subjects: 116
Study 35362891 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost and PSMA-PET/CTpre
Number of subjects: 116
Study 32758677 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mcg nebulized fentanyl
Number of subjects: 21
Study 32758677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 36120688 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation nursing based on Orem's self-care theory
Number of subjects: 60
Study 33797074 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine 12.5 mg
Number of subjects: 66
Study 33797074 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine 12.5 mg
Number of subjects: 66
Study 33797074 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 66
Study 33797074 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 66
Study 32179586 — intervention group
Group type: EXPERIMENTAL
Intervention: Global longitudinal LV strain by speckle tracking echocardiography
Number of subjects: 0
Study 32179586 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of replacement fibrosis by late gadolinium enhancement
Number of subjects: 0
Study 32179586 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 mapping techniques
Number of subjects: 0
Study 35506164 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654 (100 mg i.m.)
Number of subjects: 44
Study 35506164 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654 (300 mg i.m.)
Number of subjects: 44
Study 35506164 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654 (300 mg i.v.)
Number of subjects: 44
Study 35506164 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654 (1000 mg i.v.)
Number of subjects: 44
Study 35506164 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 35506164 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654
Number of subjects: 44
Study 33909354 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture for regulating shen and strengthening spleen, applied to acupoints Baihui (GV 20), Yintang (GV 29), Tianshu (ST 25), Shangjuxu (ST 37), and Zusanli (ST 36), treatment given once every 2 days, 3 times a week for 6 weeks.
Number of subjects: 231
Study 33909354 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium bromide, 50 mg orally, 3 times daily for 6 weeks.
Number of subjects: 231
Study 34346566 — intervention group
Group type: EXPERIMENTAL
Intervention: International nursing group
Number of subjects: 38
Study 34346566 — intervention group
Group type: COMPARATOR
Intervention: Transcultural nursing group
Number of subjects: 38
Study 34346566 — intervention group
Group type: COMPARATOR
Intervention: Complementary and alternative medicine group
Number of subjects: 38
Study 35773693 — intervention group
Group type: EXPERIMENTAL
Intervention: Xing‐Nao Kai‐Qiao acupuncture therapy plus language training
Number of subjects: 252
Study 35773693 — intervention group
Group type: COMPARATOR
Intervention: Sham‐acupoint acupuncture therapy plus language training
Number of subjects: 252
Study 33595635 — intervention group
Group type: EXPERIMENTAL
Intervention: LIRE intervention (inserting epidemiological information into lumbar spine imaging reports)
Number of subjects: 238886
Study 36433406 — intervention group
Group type: EXPERIMENTAL
Intervention: Diegetic guidance methods (specific methods not detailed)
Number of subjects: 0
Study 36433406 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand familiarity
Number of subjects: 0
Study 34509900 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Integration Scale for Adults with Psychiatric Disorders (CIS‐APP)
Number of subjects: 612
Study 34820931 — intervention group
Group type: EXPERIMENTAL
Intervention: Grid annotation ablation technique
Number of subjects: 88
Study 34820931 — intervention group
Group type: COMPARATOR
Intervention: Point-by-point ablation guided by Ablation Index (AI) annotation
Number of subjects: 88
Study 33164211 — intervention group
Group type: COMPARATOR
Intervention: Small Number books (1-3)
Number of subjects: 100
Study 33164211 — intervention group
Group type: COMPARATOR
Intervention: Large Number books (4-6)
Number of subjects: 100
Study 33164211 — intervention group
Group type: COMPARATOR
Intervention: Control (non-numerical) books
Number of subjects: 100
Study 34625847 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% fluorometholone eyedrops
Number of subjects: 120
Study 34625847 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45% ketorolac tromethamine eyedrops
Number of subjects: 120
Study 34625847 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% fluorometholone + 0.45% ketorolac tromethamine eyedrops
Number of subjects: 120
Study 34625847 — intervention group
Group type: COMPARATOR
Intervention: No eyedrops (control group)
Number of subjects: 120
Study 34168210 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse eggshell (ESC; 3-5 mm)
Number of subjects: 450
Study 34168210 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine eggshell (ESF; < 1 mm)
Number of subjects: 450
Study 34168210 — intervention group
Group type: EXPERIMENTAL
Intervention: Oyster shell (OS; 3-16 mm)
Number of subjects: 450
Study 34168210 — intervention group
Group type: COMPARATOR
Intervention: Cockle shell (CS; 1-4 mm)
Number of subjects: 450
Study 34168210 — intervention group
Group type: COMPARATOR
Intervention: Limestone (LS; < 2 mm and 2-4 mm mixed in the ratio of 3:7)
Number of subjects: 450
Study 32524226 — intervention group
Group type: EXPERIMENTAL
Intervention: IHR (Intermittent Hypoxic Breathing)
Number of subjects: 47
Study 32524226 — intervention group
Group type: EXPERIMENTAL
Intervention: IHT (Intermittent Hypoxic Training)
Number of subjects: 47
Study 32524226 — intervention group
Group type: COMPARATOR
Intervention: CON (Control)
Number of subjects: 47